Comments
Loading...
Gyre Therapeutics Stock Guidance | NASDAQ:GYRE | Benzinga
Gyre Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/17/2025 | GYRE | Gyre Therapeutics | FY | 2025 | — | — | — | $118.00M | $128.00M | $135.70M | Get Alert |
FAQ
What is the most recent guidance for Gyre Therapeutics (GYRE)?
There have been no specific sales or earnings guidance reported for Gyre Therapeutics in recent months.
Browse guidance and forecast on all stocks.
